AI assistant
Sending…
Larimar Therapeutics, Inc. — Director's Dealing 2016
Mar 10, 2016
33359_dirs_2016-03-10_9adc662e-a2d7-4a54-9cd3-30afade7852a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ZAFGEN, INC. (ZFGN)
CIK: 0001374690
Period of Report: 2016-03-03
Reporting Person: Daniel Thomas O (Director)
More from Larimar Therapeutics, Inc.
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
Mar 19
Annual Report
2026
Mar 19
Regulatory Filings
2026
Mar 19
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2